Tag: CBT > Medical Cannabis Research Cannabinoids

Medical Cannabis Access and Pricing

National Compassionate Care Council Announces Scientific Collaboration With Standard Seed Corp.

The collaboration is designed to strengthen scientific standards, product characterization, data quality, and evidence generation for cannabinoid medicine.

August 13, 2026

Medical Cannabis Access and Pricing

Medical Cannabis at Inflection Point: Policy, Science, What Comes Next (Opinion)

From New York’s clinical leadership to emerging product standards, patient care is becoming the market’s north star.

February 10, 2026

Cannabis Industry Research

UT Health San Antonio Research Shows Alzheimer’s Prevention Potential in Pairing Cannabis, Anti-Inflammatory Drug

The study revealed that combining a low-THC extract with celecoxib improved cognition. Both drugs are FDA-approved.

January 29, 2026

Industry Headlines

Tilray Medical Publishes Pioneering Research on Pharmacokinetics of THC, CBD Formulations

The new study provides insight into the bioavailability of medical cannabis formulations for therapeutic treatment.

June 26, 2025

Industry Headlines

Attorney General, DEA Director, Judge Under Federal Court Summons Over DEA Marijuana Policy

Despite the DEA’s policy, MMJ International is moving forward with the FDA on cannabis drug development for Huntington’s disease.

January 6, 2025

Cannabis Industry Research

Medical Marijuana Act Signed by Biden Would Hinder Research Under Rescheduling

The Medical Marijuana and Cannabidiol Research Expansion Act’s requirements would remain under Schedule III, a congressional researcher says.

September 20, 2024

Cannabis Industry Research

Raphael Pharmaceutical Issues Letter to Shareholders

The letter highlights the company’s exclusive relationship with Rambam Health Care Campus, differentiated cannabinoid-based technology platform, promising lead product candidate for rheumatoid arthritis, recently commenced clinical study, broader pipeline opportunities, and overall mission and vision.

July 9, 2024

Cannabis Branding Different Strains

Type I, Type II, Type III: How Science Is Changing the Way the Industry Describes Cannabis Varieties

Leaving behind the sativa-indica dichotomy, cannabis businesses must consider the chemistry of the plant.

December 7, 2023

Cannabis Industry Research

Nirit Bernstein to Speak at Cannabis Conference

Bernstein will present new research on regulating cultivation conditions for controlling secondary metabolite production in cannabis. She is one of nine scientists and university researchers sharing their findings and experiences from work in cannabis grows on topics from flushing to lighting.

May 25, 2023

CBD Industry

How 22nd Century Group Supplies Cannabinoids for Clinical Trials

Amid the FDA’s evolving guidance, the plant biotechnology company, which has long focused on the tobacco industry, has expanded to the cannabis space to create commercially desirable cultivars.

February 7, 2023

Industry Headlines

FDA Issues Final Guidance for Clinical Research on Cannabis

The nonbinding recommendations cover clinical research associated with the development of drugs that contain cannabis or cannabis-derived compounds.

January 24, 2023

Illinois

Chicago to Welcome Cannabis Research Institute

The CRI’s goal is to provide the industry with evidence-based data and promote diversity, equity and inclusion.

December 20, 2022